Table 5.
The treatment regimens and complications of PE.
| Pt | Anticoagulant therapy during stay in hospital | Phromboprophylaxis before PE | Small hematoma at injection site | Intracranial hemorrhage | Low platelet count | Subcutaneous bruises | Anticoagulation needs to be stopped due to bleeding complications | Hemorrhage in the surgical site |
|---|---|---|---|---|---|---|---|---|
| 1 | Rivaroxaban, 2 days | IPC | None | None | None | None | None | None |
| 2 | LMWH, 3 days; LMWH, 4 days | None | None | None | None | None | None | None |
| 3 | rt-PA, 2 h; dalteparin, 8 days; UFH, 6 days | IPC | None | None | None | None | None | None |
| 4 | LMWH, 3 days | IPC | None | None | None | None | Yes | Yes |
| 5 | Enoxaparin, 8 days; enoxaparin, 9 days; rivaroxaban, 2 days | IPC | None | None | None | None | None | None |
| 6 | LMWH, 10 days. | IPC | None | None | None | None | None | None |
| 7 | Enoxaparin, 6 days; urokinase, 12 days | IPC | None | None | None | None | None | None |
| 8 | UFH, 8 days; LMWH, once | None | None | None | None | None | Yes | Yes |
LMWH, low-molecular-weight heparin; UFH, unfractionated heparin; IPC, intermittent pneumatic compression; rt-PA, recombinant tissue plasminogen activator.